Insmed (INSM) Operating Expenses (2010 - 2026)

Insmed's Operating Expenses history runs 17 years deep, the most recent figure standing at $459.3 million for Q1 2026.

• On a quarterly basis, Operating Expenses rose 34.7% year-over-year to $459.3 million in Q1 2026; TTM through Mar 2026 was $2.0 billion, a 44.76% increase from a year earlier, with the FY2025 full-year figure at $1.9 billion, up 49.22% from the prior year.
• Operating Expenses retreated to $459.3 million in Q1 2026 per INSM's latest filing, from $583.6 million in the prior quarter.
• Across five years, Operating Expenses topped out at $583.6 million in Q4 2025 and bottomed at $142.9 million in Q1 2022.
• The 5-year median for Operating Expenses is $306.9 million (2024), against an average of $310.1 million.
• Across the five-year window, Operating Expenses soared 103.7% in 2023 and rose 3.58% in 2024, its largest moves.
• Year by year, Operating Expenses stood at $210.8 million in 2022, then advanced by 24.29% to $262.0 million in 2023, then advanced by 27.82% to $334.9 million in 2024, then jumped by 74.28% to $583.6 million in 2025, then declined by 21.3% to $459.3 million in 2026.
• Per Business Quant, the three latest INSM Operating Expenses figures stand at $459.3 million (Q1 2026), $583.6 million (Q4 2025), and $508.3 million (Q3 2025).